Consistent with pro-oncogenic role, it is upregulated by Her2 oncogene and by epidermal growth factor [62] and repressed by Ink4A [63, 64] in breast and pancreatic cancer. This evidence concerns the gene ERBB2 and pancreatic neoplasm.